{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:42:01Z","timestamp":1791319321820,"version":"4.3.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.hrthm.2022.12.009","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T19:52:15Z","timestamp":1670615535000},"page":"501-509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Single beta-blocker or combined amiodarone therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy\u2014defibrillator patients: Insights from the German DEVICE registry"],"prefix":"10.1016","volume":"20","author":[{"given":"Felix","family":"Wiedmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Ince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Stellbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kleemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Brachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd-Dieter","family":"Gonska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"K\u00e4\u00e4b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Perings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lugenbiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Hochadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Senges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5897-237X","authenticated-orcid":false,"given":"Constanze","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2022.12.009_bib1","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2022.12.009_bib2","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2022.12.009_bib3","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic importance of defibrillator shocks in patients with heart failure","volume":"359","author":"Poole","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2022.12.009_bib4","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1161\/CIRCULATIONAHA.117.030571","article-title":"Clinical features, management, and outcomes of immune checkpoint inhibitor-related cardiotoxicity","volume":"136","author":"Escudier","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2022.12.009_bib5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40256-020-00401-5","article-title":"Amiodarone: a comprehensive guide for clinicians","volume":"20","author":"Hamilton","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.hrthm.2022.12.009_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2022.12.009_bib7","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2022.12.009_bib8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/bcpt.13532","article-title":"Comparable risk of recurrent ventricular tachyarrhythmias in implantable cardioverter-defibrillator recipients treated with single beta-blocker or combined amiodarone","volume":"128","author":"Schupp","year":"2021","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.hrthm.2022.12.009_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijcard.2018.11.030","article-title":"Prognostic impact of beta-blocker compared to combined amiodarone therapy secondary to ventricular tachyarrhythmias","volume":"277","author":"Schupp","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2022.12.009_bib10","first-page":"CD008093","article-title":"Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death","volume":"2015","author":"Claro","year":"2015","journal-title":"Cochrane Database of Syst Rev"},{"key":"10.1016\/j.hrthm.2022.12.009_bib11","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/ehp100","article-title":"Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials","volume":"30","author":"Piccini","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2022.12.009_bib12","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/hrt.2003.025254","article-title":"Prediction and prevention of sudden cardiac death in heart failure","volume":"91","author":"Lane","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2022.12.009_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia","volume":"333","author":"Singh","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2022.12.009_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.15420\/AER.2016.10.2","article-title":"Antiarrhythmic drug therapy to avoid implantable cardioverter defibrillator shocks","volume":"5","author":"Abboud","year":"2016","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10.1016\/j.hrthm.2022.12.009_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1540-8159.1989.tb02667.x","article-title":"The effect of chronic oral and acute intravenous amiodarone administration on ventricular defibrillation threshold using implanted electrodes in dogs","volume":"12","author":"Frame","year":"1989","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2022.12.009_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0167-5273(99)00055-8","article-title":"Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment","volume":"69","author":"K\u00fchlkamp","year":"1999","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2022.12.009_bib17","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0002-9149(92)90354-2","article-title":"Effects of chronic amiodarone therapy on defibrillation threshold","volume":"70","author":"Jung","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2022.12.009_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of \u03b2-blockers, amiodarone plus \u03b2-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2022.12.009_bib19","doi-asserted-by":"crossref","first-page":"70f","DOI":"10.1016\/0002-9149(93)90966-G","article-title":"The CASCADE study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. CASCADE Investigators","volume":"72","author":"Greene","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2022.12.009_bib20","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1161\/CIRCULATIONAHA.111.072561","article-title":"Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death","volume":"124","author":"Kowey","year":"2011","journal-title":"Circulation"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527122026972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527122026972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:57:54Z","timestamp":1761548274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527122026972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1547527122026972"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2022.12.009","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single beta-blocker or combined amiodarone therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy\u2014defibrillator patients: Insights from the German DEVICE registry","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2022.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}